Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer

Affiliations

¹ Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
² Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Editorial

Vivek Verma et al. J Thorac Dis. 2018 Jan.

. 2018 Jan;10(1):21-24.

doi: 10.21037/jtd.2017.11.141.

¹ Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
² Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD. Iyengar P, et al. JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501. Epub 2018 Jan 11. JAMA Oncol. 2018. PMID: 28973074 Free PMC article. Clinical Trial.

1. Gomez DR, Blumenschein GR, Jr, Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 2016;17:1672-82. 10.1016/S1470-2045(16)30532-0 - DOI - PMC - PubMed
1. Iyengar P, Kavanagh BD, Wardak Z, et al. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol 2014;32:3824-30. 10.1200/JCO.2014.56.7412 - DOI - PubMed
1. Iyengar P, Wardak Z, Gerber DE, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 2018;4:e173501. 10.1001/jamaoncol.2017.3501 - DOI - PMC - PubMed
1. Maintenance chemotherapy with or without stereotactic body radiation therapy in treating patients with stage IV non-small cell lung cancer. Available online: https://clinicaltrials.gov/show/NCT03137771. Accessed October 29, 2017.
1. Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (SARON). Available online: https://clinicaltrials.gov/show/NCT02417662. Accessed October 29, 2017.